Abstract The Clinical High-Risk state for psychosis (CHR-P) paradigm was introduced about
2 decades ago. Over this period of time accumulating knowledge has been gained …

Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder
within 2 years. Extensive research has explored the factors that differentiate those who …

Recent evidence has suggested that psychosis could develop not only in people at clinical
high risk for psychosis (CHR-P) but also in those with clinical risk syndromes for emergent …

Primary prevention in individuals at Clinical High Risk for psychosis (CHR-P) can ameliorate
the course of psychotic disorders. Further advancements of knowledge have been slowed …

Prediction and prevention of negative clinical and functional outcomes represent the two
primary objectives of research conducted within the clinical high-risk for psychosis (CHR-P) …

Over the past 20 years there has been a great deal of research into those considered to be
at risk for developing psychosis. Much has been learned and studies have been …

After decades of research, schizophrenia and related psychotic disorders are still among the
most debilitating disorders in medicine. The chronic illness course in most individuals …

Importance Individuals can be classified as being at clinical high risk (CHR) for psychosis if
they meet at least one of the ultra–high-risk (UHR) inclusion criteria (brief limited intermittent …

Context During the past 2 decades, a major transition in the clinical characterization of
psychotic disorders has occurred. The construct of a clinical high-risk (HR) state for …

A systematic review of all reported incidence and prevalence studies of population rates of
subclinical psychotic experiences reveals a median prevalence rate of around 5% and a …